Prevalence of Depression Among U.S. Adults With Diabetes Findings from the 2006 Behavioral Risk Factor Surveillance System
ABSTRACT To estimate the prevalence rate of depression among adults with diabetes using a large population-based sample in the U.S.
Data from the 2006 Behavioral Risk Factor Surveillance System, a standardized telephone survey among U.S. adults aged >or=18 years, were analyzed (n = 18,814). The Patient Health Questionnaire diagnostic algorithm was used to identify major depression.
The age-adjusted prevalence rate of major depression was 8.3% (95% CI 7.3-9.3), ranging from a low of 2.0% in Connecticut to a high of 28.8% in Alaska. There were 25-fold differences in the rate among racial/ethnic subgroups (lowest, 1.1% among Asians; highest, 27.8% among American Indians/Alaska Natives). People with type 2 diabetes who were currently using insulin had a higher rate than people with type 1 diabetes (P = 0.0009) and those with type 2 diabetes who were currently not using insulin (P = 0.01).
Major depression was highly prevalent among people with diabetes; the prevalence rate varied greatly by demographic characteristics and diabetes types.
Full-textDOI: · Available from: Tara Strine, Feb 04, 2014
- SourceAvailable from: Mario D Garrett
[Show abstract] [Hide abstract]
- "reported that overall 8.2% of patients with diabetes in the United States also had depression but for AIAN the rate was the highest. AIANs with diabetes suffer higher rates of depression than any other ethnic group (Li et al., 2008 "
ABSTRACT: According to the 2010 Census, 5.2 million people identified themselves as American Indian or Alaska Native (AIAN) in the United States. This was an increase of 39% from the prior Census, making AIANs one of the nation’s fastest growing populations. The health and social programs reaching them, however, have experienced documented devastating shortfalls. Decades of inadequate resources have resulted in significant health and socioeconomic disparities. AIANs are often considered an “invisible minority.” In 2012, there were 266,000 AIAN elders 65 or older who claimed one race alone. That number is projected to almost triple by 2030—when the nation’s baby boomers move into the ranks of the older population. This article provides an overview of two primary mental health issues—depression and dementia—that will confront this emerging AIAN elder population. Although other health and social issues exist, this article addresses depression and dementia because they are hidden from the community and from health care agencies. This paper focuses both on the unique characteristics of the AIAN population and why it is important to address depression and dementia. The conclusion explores pragmatic policy recommendations for improving the health and long-term mental health care status of AIAN elders.The Gerontologist 02/2015; DOI:10.1093/geront/gnu181 · 3.21 Impact Factor
[Show abstract] [Hide abstract]
- "In this study, 63.5% of our studied population had depressive disorders. The prevalence of depression in our diabetic sample was higher than the range of 2%–9.5% in Iranian adults    as well as the rate of 8.3–28.8% of the diabetic patients in the United States . However, the estimates of depression prevalence among individuals with diabetes appear to be higher in developing countries . "
ABSTRACT: Introduction. Diabetes is a major public health problem. Little is known about the spiritual well-being and its relationship with quality of life (QOL) in Iranian Muslim patients with diabetes. This study investigated the spiritual well-being and QOL of Iranian adults with type 2 diabetes and the association between spiritual well-being, QOL, and depression. Methods. A cross-sectional study was done among 203 patients with type 2 diabetes mellitus in Isfahan, Iran. Quality of life and spiritual well-being were measured using the functional assessment of chronic illness therapy-spiritual well-being (FACIT-Sp). Depression was assessed using the Patient Health Questionnaire-2 (PHQ-2). Descriptive analysis, Pearson's correlation, and multiple regression analysis were performed for statistical assessment. Results. The mean QOL was 61.00 (SD = 9.97) and the mean spiritual well-being was 30.59 (SD = 6.14). Sixty-four percent of our studied population had depressive disorders. There was a significant positive correlation between all QOL subscales and meaning, peace, and total spiritual well-being score. Conclusion. The results of this study showed poor QOL and spiritual well-being and high prevalence of depression in Iranian patients with type 2 diabetes compared to other studies' findings especially western studies. This indicates the need for psychosocial and spiritual support in caring for Iranian patients with diabetes.Evidence-based Complementary and Alternative Medicine 01/2014; 2014:619028. DOI:10.1155/2014/619028 · 1.88 Impact Factor
[Show abstract] [Hide abstract]
- "In a more recent systematic review the co-existence of DM and depression was confirmed (Egede & Ellis, 2010). Interestingly rates for undiagnosed depression in DM patients as per the study conducted by Li et al. (2008) equaled to 45%. The WHO World Health Survey studied adults aged 18 and above in 60 different countries worldwide and concluded that 1 year prevalence for depression in diabetes was 2% (Moussavi et al., 2007). "
ABSTRACT: Received June 2 nd , 2012; revised July 1 st , 2012; accepted August 2 nd , 2012 Depression and diabetes mellitus (DM) have existed since ages. Yet, the etiologies of both diseases are unclear till date. However, the effects resulting from these diseases are well documented. Comorbidity of both disorders leads to increase disability and mortality rates. Besides presenting the epidemiological status of depression in DM, this review aims to highlight the different hypotheses governing the associa-tion of depression in DM and summarize the current trend in detection and management of depression. A high index of suspicion is required to detect depression in diabetic patients. There seems to be higher prevalence of depression in type 2 diabetes than in type 1 diabetes. Treatment should be tailored as per the individual needs and presence of comorbidity. Though there is no gold standard treatment for depressive diabetics, combinations of both pharmacological and non-pharmacological interventions are likely to im-prove outcomes. Selective serotonin reuptake inhibitors (SSRIs) and selective norepinephrine reuptake inhibitors (SNRIs) are preferred to conventional antidepressants. Collaborative care, psychoeducation and behavioral interventions are helpful in motivating patients to maintain treatment and improve psycho-logical well-being and quality of life. Untreated depression in diabetics is costly to the health care and economic system as there is an increase in functional impairment and mortality rate. More efforts need to be made to effectively screen, diagnose and treat patients with comorbidity of diabetes and depression.Psychology 09/2012; 3(09):787-794. DOI:10.4236/psych.2012.329119